key: cord-0874417-8opjy0pd authors: Inaba, Masato; Higashimoto, Yuki; Toyama, Yoko; Horiguchi, Tomoya; Hibino, Masaya; Iwata, Mitsunaga; Imaizumi, Kazuyoshi; Doi, Yohei title: Diagnostic accuracy of LAMP versus PCR over the course of SARS-CoV-2 infection date: 2021-04-20 journal: Int J Infect Dis DOI: 10.1016/j.ijid.2021.04.018 sha: b44cd5bb7ac4102c8dcf12857a5d3a5bd55f2c1e doc_id: 874417 cord_uid: 8opjy0pd OBJECTIVE: Reverse transcription loop-mediated isothermal amplification (RT-LAMP) has been validated for diagnosis of several viral infections. However, its diagnostic accuracy in detecting SARS-CoV-2 in real-life clinical settings remains unclear. The aim of this study was to determine the diagnostic sensitivity and specificity of RT-LAMP compared to reverse transcription-quantitative polymerase chain reaction (RT-qPCR) over the disease course of COVID-19. METHODS: A total of 124 nasopharyngeal swab samples obtained from 24 COVID-19 patients were tested by RT-LAMP and RT-qPCR. Sensitivities and specificities of RT-LAMP compared with RT-qPCR were analyzed as a function of time from onset. RESULTS: Up to the 9th day after onset, the RT-LAMP had positivity of 92.8%, and the sensitivity and specificity compared with RT-qPCR was 100%. After the 10th day of onset, however, the positivity of RT-LAMP decreased to less than 25%, and concordance of positivity between the two methods was below 60%. The limit of detection of RT-LAMP was 6.7 copies/reaction. CONCLUSIONS: Until the 9th day after the onset of symptoms, RT-LAMP had the same diagnostic accuracy as RT-qPCR. These finding suggest that RT-LAMP can be used as a diagnostic tool for COVID-19 as an alternative to RT-qPCR in the acute symptomatic phase of COVID-19. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first reported in Wuhan City, Hubei Province, China at the end of 2019 and has since caused a J o u r n a l P r e -p r o o f LAMP) method has been developed and applied as point of care tests (POCTs) for diagnosis of several viral infections (Silva et al., 2019 , Lopez-Jimena et al., 2018 . In contrast to RT-PCR, this method does not require specific skillsets or expensive reagents and instrumentation, since there is no need to denature the double strand into a single strand, and amplification and detection of genes can be completed in a single step at a constant temperature of approximately 65°C this method has the advantage of amplifying genes at a constant temperature of approximately 65°C and is relatively easy to operate . In addition, this method can produce results in less than 30 minutes. To date, several in vitro studies demonstrated that it could detect low copies of SARS-CoV-2 RNA (Ganguli et al., 2020 , Augustine et al., 2020 , Dao Thi et al., 2020 . Therefore, RT-LAMP holds promise as a POCT for detecting SARS-CoV-2. However, it is still unclear whether the method has the same diagnostic accuracy as RT-PCR in detecting SARS-CoV-2 in real-life clinical settings. Hence, we aimed to determine the diagnostic sensitivity and specificity of RT-LAMP compared to RT-PCR over the disease course of COVID-19. Clinical specimens A total of 124 nasopharyngeal swab samples obtained from 24 COVID-19 patients who were admitted to a university hospital in Japan from March 1 to April 30, 2020 were analyzed. Severity classifications were made according to the National Institutes of Health COVID-19 Treatment Guidelines (https://www.covid19treatmentguidelines.nih.gov). Swab samples were collected using a flocked sterile plastic swab applicator and placed in 3 mL of BD universal viral transport medium (Becton, Dickinson and Company, Franklin Lakes, NJ, USA). RNA was extracted from the swab samples immediately. This study was approved by the institutional review board of Fujita Health University (No. HM19-493). Total viral RNA extraction was performed with the QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany) using an automated nucleic acid extraction device, QIAcube, according to the manufacturer's instructions. The extracted RNA was eluted in 60 μL of buffer AVE and stored at −80°C. J o u r n a l P r e -p r o o f RT-LAMP was performed using the Loopamp SARS-CoV-2 Detection kit (Eiken Chemical Co., Ltd., Tokyo, Japan) according to the manufacturer's instructions. The reaction volume of 25 μL contained 10 μL of purified RNA and 15 μL of reaction mix containing 172.3 ng/μL of SARS-CoV-2 specific primer sets. The mixture was incubated for 35 min at 62.5C, and the process was monitored using a Loopamp Real-time Turbidimeter Eiken Chemical) . For visual evaluation of fluorescence, the reaction tube was illuminated with ultraviolet light using an ultraviolet illumination system (WSE-5300; ATTO, Tokyo, Japan) and also observed by the naked eye. To evaluate the genomic amount of SARS-CoV-2 RNA, one-step RT-qPCR was The clinical samples used in this study were classified into 4 groups: Group 1 with samples collected by the 9 th day from symptom onset, Group 2 with those collected between the 10 th to 19 th days from onset, Group 3 with ones collected between the 20 th and 29 th days of onset, and Group 4 with those collected 30 days or more after onset. The samples were J o u r n a l P r e -p r o o f tested by both RT-LAMP method and RT-qPCR in singlicate per sample for detection of SARS-CoV-2. 124 clinical samples obtained from 24 COVID-19 patients were tested by RT-qPCR for SARS-CoV-2 RNA quantitation. Additionally, RT-LAMP was performed using the positive samples tested by RT-qPCR. These assays were performed in singlicate per sample. To determine positivity rate of RT-LAMP for different viral load of SARS-CoV-2 and a limit of detection (LOD) of RT-LAMP with clinical samples, relationship between genomic copy number of SARS-CoV-2 RNA and RT-LAMP positivity was evaluated. Two-by-two tables were established, and analytical performance characteristics with 95% confidence intervals were calculated for sensitivity and specificity of RT-LAMP compared to RT-qPCR. Cohen's kappa (κ) was calculated as a measure of agreement with RT-qPCR. Concordance between both tests was assessed using the κ coefficient. κ values below 0.40 indicate weak correlation, values of 0.41-0.60 indicate good agreement and J o u r n a l P r e -p r o o f values above 0.60 indicate strong agreement (Landis and Koch, 1977 Patient characteristics in this study are shown in Table 1 . Of 24 COVID-19 patients included in this study, the median age was 37 years (IQR, 26.5-47.5), with 15 males and 9 females. The most common comorbidity was diabetes, followed by hypertension. Nine, 14 and 1 patients had mild, moderate and severe diseases, respectively. The median interval between symptom onset and the day of first PCR testing was 10 days (IQR, [8] [9] [10] [11] [12] . The median J o u r n a l P r e -p r o o f 11 length of hospital stay was 21.5 days (IQR, 18.3-25.0). Twelve patients received favipiravir. Twenty-two patients were discharged home after their symptoms improved and negative RT-qPCR test results were obtained from at least two nasopharyngeal specimens collected ≥ 24 hours apart. The remaining 2 patients were transferred to an isolation facility pending documentation of two negative PCR test results. Genomic copy numbers of SARS-CoV The results of 124 samples tested by RT-LAMP and RT-qPCR are shown in Table 2 . In all RT-LAMP assays, the reaction tube illuminated with ultraviolet light using an ultraviolet illumination system was evaluated by the naked eye ( Figure 2 The difference in genomic copy numbers of SARS-CoV-2 RNA determined by RT-qPCR between positive and negative RT-LAMP test results is shown in Figure 6 . The genomic copy numbers for positive RT-LAMP test results were statistically higher than those J o u r n a l P r e -p r o o f and 2.1 copies/reaction (IQR, 1.1-3.1), respectively. The limit of detection for RT-LAMP determined using the 62 RT-qPCR-positive samples was 6.7 copies/reaction. In the present study, we analyzed the sensitivity and specificity of RT-LAMP compared with RT-qPCR stratified by time from disease onset of COVID-19. Until the 9th day after the onset of symptoms, the sensitivity and specificity of RT-LAMP were 100%. This suggests that RT-LAMP has the same diagnostic accuracy as RT-qPCR in the acute phase of infection. To date, several studies have reported high sensitivity of RT-LAMP in comparison with RT-qPCR in detecting SARS-CoV-2 from clinical respiratory samples (Jiang et al., 2020 , Kashir and Yaqinuddin, 2020 , Lee et al., 2020 up to the 9th day of onset were predominantly higher than those after the 10th day of onset. In addition, genomic copy numbers of SARS-CoV-2 RNA for negative RT-LAMP test results were statistically lower than those for positive RT-LAMP test results. Therefore, low genomic copy numbers of SARS-CoV-2 after the 10th day of onset likely contributed to the lower performance of RT-LAMP in the late phase of onset. RT-LAMP can be used as a diagnostic tool for COVID-19 as an alternative to RT-qPCR in the acute symptomatic phase of COVID-19, but it is not suitable for patients presenting late in the course of illness, or to document clearance of SARS-CoV-2 among those who had a positive test previously. In the present study, we investigated how the diagnostic accuracy of RT-LAMP compared with RT-qPCR changed at intervals of 10 days. The reasons for choosing the 10day interval are as follows. First, the median interval between symptom onset and the day of J o u r n a l P r e -p r o o f first PCR testing of the 24 COVID-19 patients whose samples were collected in this study was 10 days. Second, a systematic review by Mallet et al reported that the positivity rate of RT-qPCR decreased significantly after 10 days of onset (Mallett et al., 2020) , but it is unclear how the positive rate of RT-LAMP changes after 10 days of onset. Therefore, we first compared the diagnostic sensitivity and specificity of LAMP and RT-qPCR during the first 10 days after onset, and then investigated the diagnostic accuracy of both methods at 10-day intervals after 10 days of onset. The limit of detection of RT-LAMP using the Loopamp SARS-CoV-2 Detection kit was 6.7 copies/reaction, and the positivity rate of RT-LAMP was 29.0%. Previous studies reported detection limits of RT-LAMP ranging from 1.0 × 10 1 to 1.0 × 10 2 copies/reaction, indicating that this RT-LAMP test kit has high sensitivity (Park et al., 2020 , Yan et al., 2020 . However, when the RNA copy numbers were 1.0 × 10 1 copies / reaction or less, the positivity rate of RT-LAMP was as low as 21.9%. Therefore, as previously reported, samples with a low number of RNA copies can yield false negative results by RT-LAMP. In this study, we have not evaluated the analytical specificity of the RT-LAMP method. This is because the analytical sensitivity of the RT-LAMP method using the Loopamp SARS-CoV-2 Detection kit used in this study has already been validated in our J o u r n a l P r e -p r o o f previous publication (Higashimoto et al., 2020) . Briefly, no LAMP product was detected in reactions performed with RNA from 22 viral genomes including SARS coronavirus, Middle East Respiratory Syndrome (MERS) coronavirus, other human coronaviruses, influenza viruses, and respiratory syncytial viruses associated with respiratory infections. In addition, the analytical sensitivity and specificity of the RT-qPCR method used in this study was also sufficiently validated by Shirato et al. (Shirato et al., 2020) . Therefore, we have also not performed these analyses. J o u r n a l P r e -p r o o f Saliva specimens for detection of severe acute respiratory syndrome coronavirus 2 in Kuwait: A cross-sectional study Loop-Mediated Isothermal Amplification (LAMP): A Rapid, Sensitive, Specific, and Cost-Effective Point-of-Care Test for Coronaviruses in the Context of COVID-19 Pandemic Remdesivir for the Treatment of Covid-19 -Final Report Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: A systematic review and meta-analysis Simple, Inexpensive, and Mobile Colorimetric Assay COVID-19-LAMP for Mass On-Site Screening of COVID-19 Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples Rapid isothermal amplification and portable detection system for SARS-CoV-2 Dry loopmediated isothermal amplification assay for detection of SARS-CoV-2 from clinical specimens RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2 Development and Validation of a Rapid, Single-Step Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) System Potentially to Be Used for Reliable and High-Throughput Screening of COVID-19 Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic for COVID-19 The measurement of observer agreement for categorical data Validation of a singlestep, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA Development and validation of four one-step real-time RT-LAMP assays for specific detection of each dengue virus serotype Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle At what times during infection is SARS-CoV-2 detectable and no longer detectable using RT-PCR-based tests? A systematic review of individual participant data Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Recent advances and perspectives of nucleic acid detection for coronavirus Development of Genetic Diagnostic Methods for Detection for Novel Coronavirus 2019(nCoV-2019) in Japan Loop-Mediated Isothermal Amplification (LAMP) for the Diagnosis of Zika Virus: A Review COVID-19: A Meta-analysis Detection of SARS-CoV-2 in Different Types of Clinical Specimens Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay The authors thank all of the members of clinical genetic laboratory in Fujita Health University for technical advice and discussions.